Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Nieva, A.D.
2849  Ergebnisse:
Personensuche X
?
1

25P Real-world treatment patterns and outcomes in the US af..:

Griesinger, F. ; Shah, D. ; Salomonsen, R.J-B....
ESMO Open.  9 (2024)  - p. 102604 , 2024
Link: https://doi.org/10.1016/..
 
?
2

EP03.01-02 Molecular Characterization of Non-small Cell Lun..:

Aggarwal, V. ; Xiu, J. ; Nagasaka, M....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S439-S440 , 2023
Link: https://doi.org/10.1016/..
 
?
3

MA15.08 Multicenter Phase II Trial of LN-145 TIL Cell Thera..:

Schoenfeld, A.J. ; He, K. ; Chesney, J....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S155 , 2023
Link: https://doi.org/10.1016/..
 
?
4

P2.08-06 A Phase II Study of Subcutaneous (SC) Atezolizumab..:

Qi, E.R. ; Zheng, A. ; Nocera, L.P....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S329 , 2023
Link: https://doi.org/10.1016/..
 
?
5

P2.31-02 Real-World Survival Outcomes in NSCLC in Adults Ag..:

Hsu, R. ; Poei, D. ; Macdonald, M....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S407 , 2023
Link: https://doi.org/10.1016/..
 
?
6

P2.31-01 Characterization of Survival Disparities among Asi..:

Hsu, R. ; Tsai, K.-Y. ; Nieva, J.J..
Journal of Thoracic Oncology.  18 (2023)  11 - p. S406-S407 , 2023
Link: https://doi.org/10.1016/..
 
?
7

OA13.06 The Epidemiology of Young Lung Cancer: Interim Anal..:

Bittoni, M. ; Harper, A. ; Wu, A....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S75-S76 , 2023
Link: https://doi.org/10.1016/..
 
?
8

MA04.10 Molecular Characteristics of Non-Small Cell Lung Ca..:

Zaemes, J. ; Tolulope, A. ; Elliott, A....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S112-S113 , 2023
Link: https://doi.org/10.1016/..
 
?
9

P2.31-05 Determining Lines of Therapy in Patients with Meta..:

Grady, C.B. ; Sun, L. ; Reuss, J.E....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S408-S409 , 2023
Link: https://doi.org/10.1016/..
 
?
10

EP10.01-13 Evaluating Osimertinib Induced Pneumonitis in EG..:

Ali, S. ; Nittur, V.R. ; Patel, R.P...
Journal of Thoracic Oncology.  18 (2023)  11 - p. S607 , 2023
Link: https://doi.org/10.1016/..
 
?
11

EP17.04-08 Changing Lung Cancer Incidence Trends and Risk P..:

Liu, L. ; Hsu, R. ; Nieva, J.
Journal of Thoracic Oncology.  18 (2023)  11 - p. S742 , 2023
Link: https://doi.org/10.1016/..
 
?
12

MA13.08 A Phase 1 Trial of Sapanisertib and Telaglenastat (..:

Riess, J. ; Frankel, P. ; Massarelli, E....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S91-S92 , 2022
Link: https://doi.org/10.1016/..
 
?
13

KRAS G12C mutated NSCLC and bladder cancer xenografts treat..:

Hou, S. ; Nieva, J. ; Desai, N.
European Journal of Cancer.  174 (2022)  - p. S58-S59 , 2022
Link: https://doi.org/10.1016/..
 
?
14

EP16.03-021 Developing of EGFR resistant mutations to Tyros..:

Raez, L.E. ; Baca, Y. ; Nagasaka, M....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S597 , 2022
Link: https://doi.org/10.1016/..
 
?
15

EP08.02-118 TRUST-II: A Global Phase II Study for Taletrect..:

Misako, N. ; Sugawara, S. ; Choi, C.-M....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S458 , 2022
Link: https://doi.org/10.1016/..
 
1-15